Osteoporosis: moving beyond bisphosphonates
Bisphosphonates are the mainstay of osteoporosis treatment but as more is elucidated about the underlying pathology of the condition, new drug targets are being investigated.
See the full infographic here
Prevalence and burden of osteoporosis
A complex disorder
Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2016.20201978
Recommended from Pharmaceutical Press
Pharmaceutics: Drug Delivery and Targeting systematically reviews important concepts for drug delivery systems and targeting of drugs.£24.00Buy now